CEO, Partner. Bachelor of Economics, Victoria University, Canada. Master of Financial Management, The Chinese University of Hong Kong. FMBA, Tsinghua University. Cheung Kong Graduate School of Business. Mr Wang founded Zhengfutong (Beijing) Investment Co., Ltd. and CQY Capital.

Founding partner, President of Qianyi Capital. First Class Honours Bachelor of Statistics from University College London. He worked in the onshore capital markets department of China Renaissance Capital and was involved in completing a number of private equity financing cases.

Graduated from the University of Birmingham and the University of Kent and obtained a Master's degree in Business. Graduated from Cheung Kong Graduate School of Business (2nd phase) and Hupan University (5th phase). He is currently the chairman of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., the director of Yunnan Baiyao Holding Co., Ltd., the chairman of Suzhou Yiyun Health Management Co., Ltd., and the director of Beijing Wandong Medical Technology Co., Ltd. Mr. Wu has been focusing on the medical

Bachelor degree, Changjiang Business School Relay Changjiang Phase II Student. He is currently the chairman of Shanghai Wuniu Equity Investment Fund Management Co., Ltd., and vice chairman of Haiyin Financial Holding Group. Mr. Han has taken root in China's financial industry for many years. He has invested and acquired a number of listed companies, large real estate, and led a number of private equity investment funds. The total assets under management of Wuniu Holding has exceeded 100 billion yuan in coop

Graduated from Georgia Institute of Technology, Changjiang Graduate School of Business Relay Changjiang Phase II Student. Director of Golden Mantis Co., Ltd., President of Suzhou Golden Mantis Enterprise (Group) Co., Ltd., Director of Suzhou Golden Mantis Landscape Co., Ltd., Director of Singapore Golden Mantis Co., Ltd., Director of Suzhou Golden Mantis Charity Foundation. Mr. Zhu has rich experience in investment operation in construction, real estate and manufacturing.

Senior assistant of Price Waterhouse Cooper, and take charge of M&A, listed company, IPO audit, and due diligence.

Focus on private equity and corporate law. Graduated from Temple University, as part of a joint program with Tsinghua with a concentration on American and international law. Master of Laws degree, a Bachelor of Laws, and a Bachelor of Arts. Interned at AnJie Law Firm in Beijing and Blank Rome LLP In Philadelphia.

Hold a master's degree in Chemistry from the University of St. Andrews in the United Kingdom. Research interests include transaminase inhibitors in the RMA of tuberculosis virus. PhD studied in the School of Pharmacy, Shanghai Jiaotong University. During this period, she was mainly focused in the research of asymmetric chiral hydrogenation reactions, and engaged in the industrialization of artemisinin.

Founding Partner of CDH. Board Chairman of multiple listed companies. “Top 30 Most Influential Investors in China” for many years. Leading Investor of multiple large IPOs in A/H Share and US stock market. Acquired Sirtex for 10 billion RMB with Grand Pharmaceutical.

Chairman and CEO of Yuwell Medical, Chairman of Wandong Medical. Participated in multiple health care investments including Biolight Meditech, Kangli etc.